Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Solriamfetol for the Treatment of Fatigue in Patients With Multiple Sclerosis and Excessive Daytime Sleepiness

NCT06170970 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06170970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06170970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Solriamfetol for the Treatment of Fatigue in Patients With Multiple Sclerosis and Excessive Daytime Sleepiness
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Recruiting
Start date
June 1, 2024
Completion date
March 1, 2027
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, multiple sclerosis fatigue